It's what Payments M&A, Cannabis in Ohio, President Biden's student loan forgiveness plan, Chick-fil-A's data breach, BioPharma patents, Florida tort reform, and Nigerian Interpol activities (among other regulatory matters) have in common! For your reference, here's a quick recap of some of the most widely read updates, analysis, and commentary published on JD Supra during March, 2023:
- The RESTRICT Act: A Potential New Enforcement Tool to Address Economic and National Security Concerns Posed by Foreign Information and Communications Technologies - by Giovanni Giarratana and Henry Su at Bradley
- Florida Tort Reform Now Law: Effective Upon Governor's Signature - by Steven Klein and Devin Topper at Rumberger|Kirk
- Alex Murdaugh Transcript Snafu Gives New Regard for (Human) Court Reporters’ Reliability - by the team at Calloquy
- Old School Meets New School: Critical Minerals Used in Quantum Computing - by Robert James at Pillsbury
- That Well-Endowed Canadian Teacher – What Would've Happened Here? - by Robin E. Shea at Constangy
- Critical Full Service Restrictive Covenant Compliance: Orrick’s State-by-State Survey - by Rachel Capler, Sheryl Koval Garko, Catherine Lui, James McQuade, and Amy Van Zant at Orrick
- Wrap-Up of Federal and State Chemical Regulatory Developments, February 2023 - by attorneys at Bergeson & Campbell, P.C.
- Nigeria: INTERPOL and the misinformation reports on INTERPOL’S role in the arrest of Biafran dissident Simon Ekpa - by Estlund Law, P.A.
- Genentech Files Lawsuits Against Biogen and Millennium for Past Royalties on the Cabilly Patents - by Kevin DeJong at Goodwin
- The Grandfathering Deadline for NEM 2.0 is Rapidly Approaching – What Does it Mean? - by Samir Hafez, Jonathan Kendrick, Gwenneth O'Hara at Buchalter
- The Times They Are A-Changin’: Ohio May Legalize Adult Use Marijuana in 2023 - by James Sandy, Heidi Urness at McGlinchey
- Breaking: Eye Products Supplier Facing $841 Million Judgment After Jury Returns Verdict In Decade-Long FCA Litigation - by Jeremy Abay at Pietragallo Gordon Alfano Bosick & Raspanti, LLP
- Just Right: Delaware Court of Chancery Adopts ‘Goldilocks’ Approach to Accrual of Red-Flag Caremark Claims - by M. Scott Barnard, Matthew Vernon Lloyd, Douglas Rappaport, Michelle Reed, and Jacqueline Yecies at Akin Gump
- 2023 Will be a Pivotal Year for Cannabis in Ohio - by Cheryl Burchard, Kristopher Chandler, Joseph Gross, Rachel Winder, and Robert Zimmerman at Benesch
- Independent Sponsor Spotlight: Rick Perkal of Firelight Capital - by Jon Finger at McGuireWoods
- OFAC Year in Review 2022 – Part 1 - by attorneys at Morrison & Foerster
- Biden's Student Loan Forgiveness Plan in Peril - by Teresa Biviano, Sarah Donovan, Doreen Martin at Venable
- Don't Be Fooled – April 1st Application Deadline for New Louisiana Virtual Currency License - by Bonnie Dye and Lancelle S. Lipana at Hinshaw
- Chick-fil-A Confirms Data Breach - by attorneys at Hodgson Russ
- Summary Note: Connectivity Tax/Fair Share - by Christoph Wagner at Morrison & Foerster
- Ansys goes BIG with Texas lawsuit against 213 John Doe Defendants - by Steve Vondran at Vondran Legal
- The BioPharma Patent Cliff: 2023 and Beyond - by Jason Mock at Foley & Lardner
- ChatGPT And Healthcare Privacy Risks - by Kara Du, Aileen Murphy, Cynthia Suarez at Sheppard Mullin
- Deal Flow 3.0: European Venture Capital Deal Term Review 2022 - by attorneys at Orrick
- FBI, CISA + MS-ISAC Warn of LockBit 3.0 Ransomware - by Linn Freedman at Robinson+Cole
*
Follow JD Supra's Popular channel for a fresh daily dose of top-read posts delivered each morning throughout the, directly week to your inbox..